Ken Griffin's position in Sage Therapeutics is currently worth $7 Million. That's 0.01% of their equity portfolio (1504th largest holding). The first Sage Therapeutics trade was made in Q3 2014. Since then Ken Griffin bought shares 46 more times and sold shares on 33 occasions. The investor's estimated purchase price is $9.64 Million, resulting in a loss of 27%.